CD44 glycoprotein as a prognostic factor in laryngeal cancer

Folia Histochemica et Cytobiologica

Volumn 39, Issue SUPPL. 2, 2001, Pages 150-151

  Woinska Rojecka, T ^a   Chodynicki, S ^a   Chyczewski, L ^a   Rzewnicki, I ^a  

^a NONE   (Poland)

Author keywords

CD44 glycoprotein; Laryngeal cancer; Prognosis

Indexed keywords

CELL ADHESION MOLECULE; HERMES ANTIGEN; TUMOR MARKER;

ADULT; CANCER GROWTH; CANCER SURVIVAL; CANCER TISSUE; CLINICAL FEATURE; CONFERENCE PAPER; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOWN REGULATION; EVALUATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNGECTOMY; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; POSTOPERATIVE CARE; PROGNOSIS; PROTEIN EXPRESSION;

EID: 0035686052     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Inhibition of human melanoma growth and metastasis in vivo by anti-CD44 monoclonal antibody
2. Role of CD44 variant exon 6 in invasion of head and neck squamous cell carcinoma
3. Glycoprotein CD44 expression and its association with survival in breast cancer
4. The AMeX method
5. Correlation of tumour markers P53, bcl-2, CD34, CD44H, and Ki-67 with survival and metastasis in laryngeal squamous cell carcinoma